HMGCR and breast cancer: Notwithstanding, the consistency of the mRNA data from three independent studies including the current investigation lends more support to our present recommendation that low expression of cholesterol biosynthesis genes and HMGCR is associated with favourable prognostic features and survival especially in ER positive breast cancer and may predict sensitivity to statin treatment.